The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world retrospective analysis of outcomes, treatment duration, dose intensity, and safety of enfortumab vedotin with or without pembrolizumab in urothelial carcinoma.
 
Pohua Chen
No Relationships to Disclose
 
Razwana Khanam
No Relationships to Disclose
 
Arpit Rana
No Relationships to Disclose
 
Thai Ho
No Relationships to Disclose
 
Kevin Becker
Consulting or Advisory Role - Johnson & Johnson/Janssen
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Lilly (Inst)
 
Wael Ghalayini
No Relationships to Disclose
 
Kevin Graf
No Relationships to Disclose
 
Theodore Gourdin
Consulting or Advisory Role - Pfizer; Sanofi
Research Funding - Ferring (Inst)